2026 Bio-Industry Investment Exchange & Yangling Demonstration Zone Promotion Event

Currently, the biotechnology industry is in an unprecedented period of strategic opportunity characterized by rapid development. Technological breakthroughs, policy support, and market demand are resonating in sync, driving the continuous evolution of the industrial ecosystem and the rapid expansion of its boundaries. In this context, the model of isolated efforts by individual regions or entities is no longer sufficient to address rapid technological iterations and intense global competition. Promoting cross-regional industrial collaboration and resource complementarity has increasingly become a core driver for aggregating innovation elements, enhancing overall efficiency, and thereby propelling the industry toward advanced upgrading.

Afternoon of March 12, 2026

Suzhou

(I) Organizer

Yangling Demonstration Zone Administrative Committee

(II) Organizing Unit

Yangling Demonstration Zone Industrial Investment Promotion Bureau

Yangling Demonstration Zone Industry and Commerce Bureau

Yangling Demonstration Zone Administration for Market Regulation

Beijing Danhuang Technology Co., Ltd. (VCBeat, VBDou)

(1) It is proposed to invite Cheng Jinqing, Member of the Party Working Committee and Deputy Director of the Administrative Committee of Yangling Demonstration Zone, to attend;

Responsible Comrade of the College of Life Sciences, Northwest A&F University;

Heads of the Demonstration Zone’s Investment Promotion Bureau, Industry and Commerce Bureau, and Market Supervision Administration attended.

(2) Representatives from enterprises, business associations, and research institutions in the fields of bio-manufacturing, pharmaceuticals, and medical devices in the Yangtze River Delta region will participate, with an expected attendance of approximately 30–40 people.

Thursday, March 12, 2026

Li Kui, Director of the Industrial Investment Promotion Bureau of Yangling Demonstration Zone, presided over the meeting.

14:00-14:30 Guest Arrival and Registration;

14:30-14:45 Cheng Jinqing, Member of the Party Working Committee and Deputy Director of the Administrative Committee of Yangling Demonstration Zone, delivered an address and promoted the investment environment of the Demonstration Zone;

14:45-15:00 A representative from the College of Life Sciences, Northwest A&F University, presents the college's scientific research achievements;

15:00-15:15 A representative from the Industry and Commerce Bureau of Yangling Demonstration Zone introduces the planning for the Provincial Future Industry Pilot Zone for Biomanufacturing;

15:15-16:30 Speeches by Key Enterprises (10 minutes per company)

16:30-17:30 Interactive Exchange and Policy Q&A;

Partial List of Recommended Companies—

1. Kunshan Boqing Biotechnology Co., Ltd.(Kunshan Boqing Biotechnology Co., Ltd. is a high-tech enterprise and a specialized, refined, distinctive, and innovative small and medium-sized enterprise (affiliated with Ruiyang Bio), established in 2006 and located in Yushan Town, Kunshan City, Jiangsu Province. The company is committed to addressing veterinary drug resistance through biotechnology, specializing in the production of veterinary drugs, disinfection products, and the research and development of biological enzymes and antimicrobial peptides. It has launched featured topical antibacterial products for pets, such as “Baofuning.”)

2. Suzhou Kangruijian Biomedical Technology Co., Ltd.(Established in 2020 and headquartered in Suzhou New District, the company is a technology-driven micro and small enterprise focused on the R&D, production, and sales of biomedical materials. Leveraging the expertise of Professor Jiang Xulin’s team at Wuhan University, it specializes in novel thermosensitive chitosan and other polymeric materials for Class II and III medical devices in fields such as medical aesthetics and orthopedics. The company has received investment from Huayi Capital.)

3. Suzhou Juwei Yuanchuang Biotechnology Co., Ltd. (Suzhou Juwei Yuanchuang Biotechnology Co., Ltd., established in 2018 and headquartered in the Suzhou New District, is a technology-based small and medium-sized enterprise focused on non-grain biomass conversion and synthetic biology. Leveraging AI-driven enzyme engineering and engineered microbial strain technologies, the company converts agricultural and livestock waste (such as straw) into high-value bio-based materials (e.g., succinic acid) and animal nutrition products, committed to achieving industrialized, low-cost green biomanufacturing.

4. Suzhou Frankman Medical Instrument Co., Ltd.(The company positions itself as a “Chinese expert in surgical instruments,” focusing on the research and development of intelligent platforms and energy-based platforms. Its products have obtained multiple international certifications, including SFDA, FDA, and CE. The company has established sales networks in more than 50 countries and regions worldwide and is a well-known innovative domestic brand in the field of diagnosis and treatment of digestive and respiratory diseases.)

5. Shaanxi Hisfer Bioengineering Co., Ltd.(The company specializes in the field of bioengineering, with its core business covering the research, development, and production of functional food ingredients, natural flavors, bio-based materials, plant-derived pharmaceutical raw materials, pharmaceutical intermediates, microencapsulated powders, cosmetic ingredients, and feed additives. Its core products include fermented carotene, lycopene, oil microencapsulated powder, natural vitamin E, and phytosterol esters. The company holds quality management system certifications such as ISO 9001 and GMP.)

6. Xi'an Huayue Sheng Biotechnology Co., Ltd.(Focused on the development and production of key industrial enzyme preparations required by the biotechnology industry, we provide customized development and manufacturing of specialized industrial enzyme preparations for the biomedical sector both in China and globally, delivering solutions for human health, industrial environmental protection, and sustainable development.)

Consultation Contact: 18983840973